In this webinar, we will discuss the benefits of engaging a seasoned consulting organization, such as IQVIA, to perform a regulatory gap assessment, and we'll examine evolving industry regulations and their proposed changes that could impact life sciences manufacturing operations and quality practices.
Key Takeaways:
- Acquiring a company due diligence process
- Preparing for regulatory inspections
- When and how to conduct a general assessment if significant time has passed since a regulatory agency performed an on-site inspection
- Gap assessments for potential suppliers of a contract service (e.g., manufacturing or laboratory)
- Emerging Biopharma- what gaps should be filled prior to commercialization?
Speaker
Michael Hidock
Principal, Quality and Compliance Services IQVIA
